PATENT CLAIM ANALYSIS

Application Number: 15744723
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "497000"]

Abstract:
Nanopaiticle compositions described herein comprise combinations of prodrugs of therapeutic agents that achieve enhanced therapeutic effects as compared to those observed when combinations of free forms of these therapeutic agents are administered.

Claim (Index 6):
The composition of  claim 1  wherein in each of said prodrugs the hydrophobic moiety is cholesterol and/or the linker is diglycolic acid.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.26923
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13363822', '13915049', '13478691', '13659460', '12485406']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7351690998364036
- 35 USC 102 Novelty (BERT): 0.5051162343623644
- Combined Prediction Score: 0.7121638132889996
- Mean Citation Score: 237.994782
- Max Citation Score: 240.42374
- Similarity Product: 157.9095318738544

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test